Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

260

LikeLikedUnlike

241-255 of 347

Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
NeuroFrontiers
Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Carri Polick, PhD, RN
  Peer
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
NeuroFrontiers
MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics
- Jennifer Caudle, DO, FACOFP
  Peer
- Mitzi Joi Williams, MD
  Peer
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
NeuroFrontiers
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Anibal Chertcoff, MD
  Peer
Examining Emerging Gut Microbiota Biomarkers for MS
NeuroFrontiers
Examining Emerging Gut Microbiota Biomarkers for MS
MS in Children: Exploring Biomarker Research Advancements
NeuroFrontiers
MS in Children: Exploring Biomarker Research Advancements
- Ahmed Abdelhak, MD
  Peer
New Consensus for Smoldering Disease in MS
NeuroFrontiers
New Consensus for Smoldering Disease in MS
advertisement
Discussing Disparities in MS Care for Underrepresented Populations
NeuroFrontiers
Discussing Disparities in MS Care for Underrepresented Populations
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Tirisham V. Gyang, MD
  Peer
- Gopika Govindan Kutty, MD
  Peer
An Overview of MS Biomarkers
NeuroFrontiers
An Overview of MS Biomarkers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
NeuroFrontiers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jay Avasarala, MD, PhD
  Peer
Supporting the Peripartum Period Through Perinatal Psychiatry
NeuroFrontiers
Supporting the Peripartum Period Through Perinatal Psychiatry
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Nichelle Haynes, DO
  Peer
Highlights from the 2023 Psych Congress
NeuroFrontiers
Highlights from the 2023 Psych Congress
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Craig Chepke, MD, FAPA
  Peer
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
NeuroFrontiers
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
advertisement
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiers
Diagnosing Suspected MS: A Review of the Updated Guidelines
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Eoin Flanagan, MB, BCh
  Peer
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiers
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Psych Congress Action Center
Locked Up in My Own Mind: Challenges in the Criminal Justice System

Program Chapters

Segment Chapters

Playlist:

Recommended